Measles
Submitted by Anonymous (not verified) on 28 April 2025 - 11:20
Measles
EudraVigilance Expert Working Group (EV-EWG) work programme 2025-2026
Submitted by Anonymous (not verified) on 28 April 2025 - 8:32
EudraVigilance Expert Working Group (EV-EWG) work programme 2025-2026
Summary of opinion: Xofluza, 25/04/2025 Positive
Submitted by Anonymous (not verified) on 28 April 2025 - 8:06
Summary of opinion: Xofluza, 25/04/2025 Positive
Human medicines European public assessment report (EPAR): Alunbrig, brigatinib, Date of authorisation: 22/11/2018, Revision: 10, Status: Authorised
Submitted by Anonymous (not verified) on 25 April 2025 - 16:30
Human medicines European public assessment report (EPAR): Alunbrig, brigatinib, Date of authorisation: 22/11/2018, Revision: 10, Status: Authorised
Human medicines European public assessment report (EPAR): Elocta, efmoroctocog alfa, Date of authorisation: 18/11/2015, Revision: 15, Status: Authorised
Submitted by Anonymous (not verified) on 25 April 2025 - 15:40
Human medicines European public assessment report (EPAR): Elocta, efmoroctocog alfa, Date of authorisation: 18/11/2015, Revision: 15, Status: Authorised
Summary of opinion: Amvuttra, 25/04/2025 Positive
Submitted by Anonymous (not verified) on 25 April 2025 - 15:06
Summary of opinion: Amvuttra, 25/04/2025 Positive
Summary of opinion: Veklury, 25/04/2025 Positive
Submitted by Anonymous (not verified) on 25 April 2025 - 15:05
Summary of opinion: Veklury, 25/04/2025 Positive
Summary of opinion: Calquence, 25/04/2025 Positive
Submitted by Anonymous (not verified) on 25 April 2025 - 15:05
Summary of opinion: Calquence, 25/04/2025 Positive
Summary of opinion: Vyvgart, 25/04/2025 Positive
Submitted by Anonymous (not verified) on 25 April 2025 - 15:05
Summary of opinion: Vyvgart, 25/04/2025 Positive
Summary of opinion: Jivi, 25/04/2025 Positive
Submitted by Anonymous (not verified) on 25 April 2025 - 15:05
Summary of opinion: Jivi, 25/04/2025 Positive